65,437 trials
Head and Neck Neoplasms
Primary: Response (CR or PR), Stable Disease (SD), and Progressive Disease (PD) Rates — 6.81; 18.18; 75.00 percentage of participants
Erythematotelangiectatic Rosacea
Primary: Response Rate for Achieving a 2 Grade Improvement on Clinician's Erythema Assessment (CEA) and Patient Self Assessment (PSA) Over 12 Hours After Dosing. — 17; 10; 7; 4…
Disorder Related to Renal Transplantation
Primary: Number of Participants With Acute Rejection (AR) of Transplant up to 6 Months Post Transplantation - Intent to Treat (ITT) Population — 4; 1; 1; 0 participants
Rosacea
Primary: Composite Success — 36; 13; 36; 13 participants — p=<0.001
Influenza Caused by the Novel Influenza A (H1N1) Virus
Primary: Haemagglutination Inhibition (HI) and Microneutralisation (MN) Antibody Titre Seroconversion Rate After the First Vaccination — 74.2; 81.5; 77.5; 75.6 percentage of…
Diphtheria · Tetanus · Pertussis
Primary: Percentage of Participants With Seroconversion for Anti-pertussis Toxoid and Anti-filamentous Hemagglutinin Antibodies Post-vaccination With Either DTaP-IPV-Hep B-PRP~T…
Recurrent Adult Soft Tissue Sarcoma · Stage III Adult Soft Tissue Sarcoma · Stage IV Adult Soft Tissue Sarcoma
Primary: Confirmed Tumor Responses — 0; 0 participants
Diphtheria · Tetanus · Pertussis
Primary: Summary of Antibody Persistence and Immunogenicity Booster Response in Participants Who Were Vaccinated With Either DTaP-Hep B-PRP~T Concomitantly With Oral Polio…
Urinary Incontinence, Urge
Primary: Percent Change in Urgency Urinary Incontinence Episodes Per Week — -33; -6 Percent Change
Colorectal Neoplasms
Primary: Percentage of Participants With Objective Response — 3; 20 Percentage of Participants — p=0.0735
Rosacea
Primary: Composite Success — 40; 14; 39; 12 participants — p=<0.001
Lennox-Gastaut Syndrome
Primary: Percent Change in Tonic-Atonic Seizure Frequency From Baseline (Per 28 Days) — -24.20; -3.25 Percent Change — p=0.003
Adenocarcinoma
Primary: Progression-free Survival (PFS) — 91; 148 days
Adenocarcinoma of the Pancreas · Recurrent Pancreatic Cancer · Stage II Pancreatic Cancer
Primary: Objective Response Rate (Complete or Partial Response) Evaluated Using the Response Evaluation Criteria in Solid Tumors (RECIST) — 21; 21 percentage of participants…
Streptococcus Pneumoniae Infections
Primary: Percentage of Participants With Carriage of Streptococcus Pneumoniae in Nasopharynx — 12.6 Percentage of Participants